Abingdon Health (UK) Today
| ABDX Stock | 7.25 0.25 3.57% |
PerformanceVery Weak
| Odds Of DistressAbove Average
|
Abingdon Health is selling for under 7.25 as of the 22nd of March 2025; that is 3.57 percent increase since the beginning of the trading day. The stock's lowest day price was 7.02. Abingdon Health has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Moving against Abingdon Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Abingdon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Abingdon Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abingdon Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive Chairman | Christopher Hand |
| Thematic Ideas | (View all Themes) |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Management, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) |
Abingdon Health Plc (ABDX) is traded on London Exchange in UK and employs 84 people. Abingdon Health is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abingdon Health's market, we take the total number of its shares issued and multiply it by Abingdon Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abingdon Health Plc operates under Biotechnology sector and is part of Health Care industry. The entity has 189.52 M outstanding shares.
Abingdon Health generates negative cash flow from operations
Check Abingdon Health Probability Of Bankruptcy
Ownership AllocationAbingdon Health holds a total of 189.52 Million outstanding shares. Abingdon Health Plc retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Abingdon Ownership Details
Abingdon Health Plc Risk Profiles
Although Abingdon Health's alpha and beta are two of the key measurements used to evaluate Abingdon Health's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.06 | |||
| Standard Deviation | 2.47 | |||
| Variance | 6.12 | |||
| Risk Adjusted Performance | (0.02) |
Abingdon Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abingdon Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Abingdon Health Corporate Management
Elected by the shareholders, the Abingdon Health's board of directors comprises two types of representatives: Abingdon Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abingdon. The board's role is to monitor Abingdon Health's management team and ensure that shareholders' interests are well served. Abingdon Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abingdon Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Yates | CEO Director | Profile | |
| Mark Jones | Chief Officer | Profile | |
| Melanie Ross | Company CFO | Profile | |
| Nina Garrett | Head Devel | Profile | |
| Oliver Gardner | Chief Officer | Profile | |
| Laura Towse | Group Controller | Profile |
Additional Tools for Abingdon Stock Analysis
When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.